Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

#143 (March 06, 2024) 'Principle Trial Review and Open Q&A': FLCCC Weekly Update

#143 (March 06, 2024) 'Principle Trial Review and Open Q&A': FLCCC Weekly Update

FromFLCCC Alliance


#143 (March 06, 2024) 'Principle Trial Review and Open Q&A': FLCCC Weekly Update

FromFLCCC Alliance

ratings:
Length:
68 minutes
Released:
Mar 14, 2024
Format:
Podcast episode

Description

In this FLCCC Weekly Update, Dr. Pierre Kory was scheduled to talk with Andrew Bridgen to discuss the issue of excess deaths. The conversation had to be delayed, but there was no shortage of intrigue. Instead, Dr. Kory took us through the results of the conspicuously low-profile publication of the seventh major study on ivermectin. It was a study they designed to fail, but still showed positive results. Join us for a curious look into the latest ivermectin takedown.
Formed by leading critical care specialists in March 2020, the Front Line COVID-19 Critical Care Alliance (FLCCC) has developed highly effective treatment protocols that aim to prevent and treat COVID-19 at all stages of the disease.
We are a 100% donor-supported 501(c)(3) non-profit organization — our work would not be possible without you.
Your gifts help us expand our reach and share the latest research available, for the health and well-being of all.
To donate online, click here:https://covid19criticalcare.com/network-support/support-our-work/
To follow FLCCC, click here:https://covid19criticalcare.com/follow-flccc-2/
To learn more about our protocols, click herehttps://covid19criticalcare.com/covid-19-protocols/
To register for weekly webinars, click here:https://geni.us/FLCCC_Webinar_Register
To buy FLCCC gear, click here:https://supportflccc.store/
Released:
Mar 14, 2024
Format:
Podcast episode

Titles in the series (100)

The FLCCC Alliance was organized in March 2020 by a group of highly published, world renowned Critical Care physician/scholars – with the academic support of allied physicians from around the world. The organization’s goal is to research and develop lifesaving protocols for the prevention and treatment of COVID-19 in all stages of illness.